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Quantiﬁcation and three-dimensional microanatomical organization of
the bone marrow
Cesar Nombela-Arrieta and Markus G. Manz
Hematology, University Hospital and University of Zurich, Zurich, Switzerland
Bone marrow (BM) constitutes one of the largest organs in mice and humans, continuously
generating, in a highly regulatedmanner, red blood cells, platelets, andwhite blood cells that
together form the majority of cells of the body. In this review, we provide a quantitative
overview of BM cellular composition, we summarize emerging knowledge on its structural
organization and cellular niches, andwe argue for the need ofmultidimensional approaches
such as recently developed imaging techniques to uncover the complex spatial logic that
underlies BM function in health and disease.
Since Neumann and Bizzozero independently proposed in 1868 that the origin of blood cells was to be
found in soft tissues contained inside bone cavities, the bone marrow (BM) has continued to fascinate
scientists and clinicians alike.1,2 Yet more than a century later, our understanding of how the
hematopoietic, immune, and bone-forming tasks of the BM are tightly controlled and integrated in the
context of one common anatomical space is still incomplete.
Methodological approaches and advances to study BM tissues
Early studies on BM cellular composition and microarchitecture date back to the 19th century when the
first biopsies of marrow content were performed in living individuals.3 Microscopic observation of BM
smears and examination of histological sections became the standard technique, which is still used to
this day to study, diagnose, and classify hematologic disorders. The realization in the post–World War II
era that transplantation of BM cells from healthy individuals could rescue the lethal effects of high-dose
irradiation on hematopoiesis galvanized scientific interest in BM and lead to the development of methods
to detect and measure hematopoietic stem and progenitor cell (HSPC) activity, absolute cellularity,
lineage-specific half-lives, and kinetics of cell production in the BM of humans and in laboratory
animals.4,5 Gradual improvements in light and electron microscopy further refined the understanding of
the quantitative composition and ultrastructural features of BM tissues.6 The biggest leap in the fields of
immunology and hematology came with the advent of recombinant antibody technology and flow
cytometry in the 1960s. These breakthroughs permitted the identification, quantification, and isolation of
diverse populations from highly heterogeneous cell suspensions through detection of phenotypic traits.5
Indeed, to this day, flow cytometry remains the technological mainstay for the study and dissection of the
hematopoietic system.
Immunolabeling methods were further adopted in modern fluorescence-based microscopy to
discriminate cellular phenotypes in tissue sections and study cellular organization in the BM. In recent
years, confocal microscopy has become the most popular modality to define spatial relationships and
study developmental-stage specific localization patterns, with a keen interest of many groups in the
dissection of HSPC niches.7 In addition, intravital multiphoton microscopy is employed to obtain
dynamic images of the most superficial layers of BM beneath bone surfaces, leading to seminal
discoveries on cellular interplay and trafficking.7,8 A spectacular enhancement in the quantitative power
of microscopy techniques is currently being driven by technological advances, which include the
development of (1) protocols that render organs almost completely transparent for volumetric imaging9;
(2) novel modalities of optical imaging such as light sheet microscopy or optical projection tomography
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for faster, automated acquisition of multidimensional images of
large tissue regions or entire organs10,11; (3) more sophisticated
excitation and detection systems that enable increased multi-
plexing; and (4) bioimage-based analysis software tools to facil-
itate the unbiased extraction of cytometric measurements and
computation of quantitative spatial information from complex,
high-dimensional data sets.12 Thus, it is now becoming possi-
ble to generate and analyze organ-wide three-dimensional (3D)
reconstructions of a variety of tissues including BM and spleen
with cellular and subcellular resolution (Figure 1).13-15 Collec-
tively, multidimensional microscopy techniques hold great pro-
mise to take our understanding of the global microanatomy of
hematopoiesis to the next level, that is, one in which distinct
stages of development along the hematopoietic continuum are
precisely resolved and mapped into a panoramic view of BM
topology.
Cellular content of BM tissues in mice
and humans
Intraosseous marrow tissue masses distributed inside the different
long, short, and flat bones of the organism constitute one of the
largest organs in humans, accounting for 4% to 5% of total body
weight,16,17 therefore exceeding other major vital organs such as
brain (2%), liver (2.6%),18 heart (0.5%),19 or the entire network of
secondary lymphoid organs (1% to 1.5%).18 In a “standard” 70 kg
adult human, BM tissues weigh;3 kg and occupy a volume of 1.5 to
3 L (Table 1). BM is the most prominent source of de novo cellular
generation, reaching rates of 4 3 1011 to 5 3 1011 cells per day in
adult humans (0.5-1.53 109 in mice),20-23 which outnumber those of
other tissues of high turnover such as intestinal epithelium (1011 cells
per day)24 or testis (100-300 3 106 spermatozoids per day). To
achieve this, it is estimated that BM tissues collectively deliver daily
to systemic circulation the equivalent of half of their total cellular
content, although only approximately one-fourth of produced cells are
nucleated. Remarkably, at any given moment, 90% of total cell
numbers of the organism originates from or resides in the BM, with
anuclear erythrocytes and platelets accounting for the majority of it.25
A detailed census of BM hematopoietic cellular constituents in
humans and animal models has been generated through the use
of flow cytometry (Table 2). Despite the transient and dynamic
nature of its hematopoietic components, which results in an ever-
changing cellular landscape, the relative proportions of different
lineages remain consistently uniform between different bone
cavities, strongly arguing for the existence of robust systemic
signals that control BM cellular content.26 Rare, self-renewing
HSPCs lie at the apex of the system’s hierarchy and give rise
to myriads of oligopotent, highly proliferative progenitors that
sequentially progress along the hematopoietic hierarchy.27
Collectively, the most primitive compartment including HSPCs
and multipotent cells only comprises a minor part of the cellular
content of the marrow (Table 2). Otherwise, BM spaces team
with differentiating and fully mature cells, predominantly of the
myeloid lineage, which mostly includes immature and mature
granulocytes. Myeloid prevalence is significantly more accentu-
ated in human compared with murine BM, where the B-cell
lineage represents a more sizeable fraction of BM content. In both
systems, however, aging results in an increased myeloid content
at the expense of lymphoid lineages through a lineage-biased
molecular program, which is activated already at the level of the
most primitive HSC subsets.28,29
Notably, flow cytometric analyses are typically restricted to BM
mononuclear cells, thus neglecting the contribution of some of the
most frequent cell types, such as erythrocytes, platelets, and the
rarer but still relatively frequent megakaryocytes.30 Although flow
cytometry has started to be applied to study the composition of
densely packed nonhematopoietic stromal meshworks formed by
endothelial, mesenchymal, and neural cells, these are hard to
dissociate into liquid suspensions of viable cells. It is therefore
unclear to what extent stromal subsets extracted by enzymatic
digestion quantitatively and qualitatively relate to the overall
composition of the BM microenvironment in vivo. For instance, a
number of studies using fluorescent reporters or immunopheno-
typical signatures have indicated that in mouse BM, mesenchymal,
and vascular cells account for ,1% of total mononuclear cellular
pool.31-35 However, by direct comparison with imaging data14,31
(Figure 1B) it becomes unequivocally obvious that such quantifica-
tions result in a vast underestimation of these cell types, a limitation
worth taking into account when drawing conclusions on the
physiological relevance of stromal subsets.
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Figure 1. Three-dimensional imaging of BM. (A) Representative stages of murine femoral bones during processing for 3D imaging as described in Nombela-Arrieta et al.13 From
left to right: unsectioned, sliced unprocessed, and optically cleared BM slices. The last 2 images to the right correspond to an example of 3D reconstruction of the entire BM
microvascular system of the femur (arteries and sinusoids) using multidimensional confocal imaging of a cleared BM slice. A detailed view of the central sinus running along the
longitudinal axis of the marrow is provided. (B) High-resolution 3D imaging of a reduced field of view showing sinusoidal vessels (red) and the network of perivascular bodies of CAR
cells (green), forming a dense matrix through the emission of abundant cytoplasmic projections.
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The 3D organization of BM tissues and
cell-specific niches
Beyond the enumeration of cellular components, in depth knowl-
edge on tissue structural assembly and 3D microarchitecture is
essential for the detailed understanding of multicellular organ
function.36 The definition of a BM microstructural standard is
confounded by the fact that BM tissues are dispersed throughout
bone cavities that greatly differ in size and morphology. Following
general macroscopic criteria of bone morphology, 2 types of BM
regions are distinguished: (1) Trabecular or cancellous bone
regions, mostly present in flat and irregular bones, as well as the
epiphysis and metaphysis of long bones, contain BM islands
interspersed within a labyrinth of boney trabeculae.37 (2) Cortical
bone is found in the diaphysis or shafts of long bones, which is
predominant in human and mouse skeletal systems. Trabecular
regions are most active in terms of bone remodeling, contain an
increased endosteal surface/BM volume ratio, and are more
densely vascularized. Despite obvious anatomical differences, only
minor variations in hematopoietic content and physiology between
both types of BM spaces have been documented.14,26,38
Stromal scaffolds in BM. Given the rapid turnover of most
hematopoietic cells, stromal scaffolds provide the immanent 3D
infrastructure for BM tissue integrity.39 Vascular networks, aside from
essential functions of nutrient delivery, waste removal, cellular
trafficking, and angiocrine-mediated regulation of hematopoiesis,
fulfill important structural roles.40 Using 3D imaging, we and others
have provided a detailed 3D overview of the microarchitecture of
the microvascular system in different bones, which is composed
of arterial and sinusoidal vessels (the venous equivalent of the
BM), interconnected through a recently defined intermediate
vascular type.13,14,32,41,42 Collectively, the pervading BM vascular
tree occupies 15% to 30% of the volume of BM, most of which
corresponds to the wide, highly branched, labyrinth-like sinusoidal
network32 (C.N.-A., unpublished data) (Figure 1A). In essence, the
vast majority of BM cells lie proximal to sinusoidal surfaces,14
thereby illustrating the potentially massive influence of endothelial
components in the regulation of hematopoiesis in steady state as
well as during adaptation to stress conditions. Indeed, dynamic
reactive changes in vascular morphology and diameter correlate
with drastic shifts in blood and BM cellular content43,44 (C.N.-A.,
unpublished data).
The mesenchymal compartment is thought to organize as a
developmental hierarchy, which according to recent data, could
be as diversified as its hematopoietic counterpart.45,46 The largest
fraction of the BM mesenchymal component presents in the form of
a dense weblike network of perivascular cell bodies interconnected
Table 1. Representative parameters of BM function in humans and mice
Parameters Humans Mice Reference(s)
Total weight of BM (relative to body mass) 4%-5% 1.5%-2% 16-18, 73, 74
Weight in standard individual 3 kg 0.4-0.5 g 18, 73, 75
Total volume BM 1100-2100 cm3 0.35-0.4 cm3 73, 74, 76
Total volume blood 70-80 mL/kg 85-95 mL/kg 18, 77
Blood volume in the BM (% of tissue volume) ND 15%-30% 32; C.N.-A., unpublished data
Ratio cortical/trabecular bone 80:20 65:35 37, 78
Nucleated BM cells per kg body weight (1.1-2.1) 3 1010 (1.1-1.8) 3 1010 79, 80
Total nucleated BM cells (0.8-1.5) 3 1012 (2.8-5.2) 3 108 79-81
Cell production per day
Total (4-5) 3 1011 ([5-7] 3 1010
cells per kg)
(0.5-1.5) 3 109 ([2-6] 3 1010
cells per kg)
20
RBCs 2.2 3 1011 (0.45-0.85) 3 109* 21
Platelets (1-1.75) 3 1011 (0.16-0.7) 3 109* 22
Neutrophils (0.45-1.2) 3 1011 (0.7-1.9) 3 107 23, 82
Major BM cavities (% of total BM content) Lower limbs, 26%-38% Vertebrae, 32%-52% 16, 17, 80, 81, 83
Vertebrae, 14%-28% Lower limbs, 14%-20%
Pelvis, 16% Pelvis, 25%
BM adipogenesis (% of BM volume) 50%-70% (age 25) 1%-2% in 12 wk old 60, 84-86
18%-20% in 56 wk old (measured in
proximal tibial metaphysis)
Number of HSCs (functional definition) (28-112) 3 106† 11 200-22 400 87
Myeloid:erythroid ratio 3:1 1.7:1-2.3:1 73, 88, 89
Published estimated values on BM composition and function. Values depicted have been in most cases obtained for, or adjusted to, a reference standard individual of 70 kg for humans and 25 g
for mice.
HSC, hematopoietic stem cell; ND, not determined; RBC, red blood cell.
*Rates of erythrocyte and platelet production in mice have been here estimated as described by Palis21 by using available data on the specific half-lives and total numbers in blood.
†Reliable estimations of total HSC numbers in humans are lacking to date. As depicted, for most parameters presented, including weight and blood cell production, the ratio of values between
mouse and human species falls approximately with a range of 2500 to 5000. The theoretical number of HSCs for the human system provided in this table has been estimated assuming that similar
ratios would apply for proportional scaling of HSC content between species.
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through large cytoplasmic projections that pervades entire BM
tissues (Figure 1B). These fibroblast-like reticular cells have been
generically defined in mice by expression of common markers
(leptin receptor and CD140a), and the secretion of large amounts,
at least by a substantial fraction of this population, of regulatory
factors such as interleukin-7 (IL-7), stem cell factor, and
CXCL12.31,47-50 For this feature, they were first visualized in the
CXCL12-GFP knock-in mouse model and termed CXCL12-
abundant reticular (CAR) cells.51 Multiple studies have now shown
that CAR cells are fundamental players in the regulation of specific
and very distinct stages of hematopoiesis. How they exert such
seemingly diverse regulatory actions is poorly understood and
points to the presence of a high heterogeneity within this population
that is yet to be dissected. The CAR cell network is also an essential
component of the skeletal system as it includes bipotent progenitor
cells, which are the source of newly formed osteoblasts and
adipocytes during adulthood.31,52 Terminal osteoblastic differenti-
ation is proposed to take place in a continuous fashion along inner
bone surfaces where mature osteoblasts reside,53 but the precise
cellular intermediates through which osteo-and adipogenic lineage
differentiation progress are not well defined, and thus their spatial
localization in BM tissues has not been mapped in detail. Although
incompletely defined, a human counterpart of CAR cells, with
similar osteoprogenitor and hematopoietic supporting potential, has
been described.54 Mesenchymal progenitor cells have also been
reported to include a subset of rare, Nestin-GFPhi NG21 elongated
cells, which run along the trajectory of the arterial network, adjacent
to nonmyelinating Schwann cells and sympathetic nerves, forming
anatomically distinct neurovascular structures.32,55 On the basis
of expression of distinct phenotypic signatures, the presence in BM
of additional cellular subsets of mesenchymal origin have been
reported.34,56 Yet the quantitative and structural contribution of
such populations to BM tissues, their potential role in hematopoietic
regulation, as well as their specific developmental position in current
models of mesenchymal differentiation are still to be dissected.
BM adipogenesis from reticular cells takes place gradually and
asymmetrically in different bone locations during physiological
aging, a process that is more conspicuous in humans than mice.
Adipocytic infiltration is prominently induced in stress conditions
such as irradiation, and correlates with a degeneration of vascular
structures, lower bone formation rates,57 and reduced hematopoi-
etic activity.58 The mechanisms driving spatial patterning of
adipogenesis and its impact in the integrity of neighboring vascular
and mesenchymal structures are poorly understood. Of note,
multiple studies suggest that marrow adipose tissue is heteroge-
neous in terms of adipocytic and lipid content, regional distribution,
and regulatory function.59,60 Finally, stromal cell networks are built
around the proteic acellular backbone created by fibers of
extracellular matrix (ECM). Studies in BM and other lymphoid
organs indicate that highly plastic ECM networks could play vital
roles in steady state as well as pathological hematopoiesis.61,62
However, not much is known to date on the heterogeneity,
biochemical composition, and topology of BM ECM.
Spatial organization of hematopoiesis. How the succes-
sion of orderly events that leads to continuous hematopoiesis
develops within the described tissue microfabric remains poorly
understood. Unlike other hematolymphatic organs such as thymus
and lymph nodes,36 no conspicuous regionalization of lineages,
developmental stages and/or cellular processes has been
Table 2. Cellular content of the BM as determined by flow cytometry
Populations
Humans Mice
Phenotype
Frequency of
BMMNC (%) Reference(s) Phenotype
Frequency of
BMMNC (%) Reference(s)
HSCs Lin2CD341CD382CD901CD45RA2 0.01-0.2 27, 28 Lin2c-kit1Sca-11(LSK) 90
CD482CD1501 0.004-0.007
Common myeloid
progenitors
Lin2CD341CD382CD1231CD45RA2 0.2-0.8 28, 91 Lin2c-kit1 0.4 92
CD341CD16/32lo
Common lymphoid
progenitors
Lin2CD341CD381 0.02-0.18 28 Lin2c-kit1CD1271 0.02 93
CD1271
Erythroid progenitors CD2351CD711 4-16 94 Ter1191 5-15 26, 95
Granulocytes CD661 57-86 94, 96 Gr-11 30-50 26, 95
Megakaryocytes * 0.05 22 CD411 0.29 30
Monocytes CD141 2-5.8 94, 97 CD1151CD11b1Ly6C1 5-7 98
B-cell lineage (including
progenitors)
CD191 1-7 94, 96 B220 35-45 26
T lymphocytes CD451CD662CD342CD142 8-20 94, 97 CD31 4-5 26, 83
CD81 2
Endothelial cells CD452Ter1192CD311 ND CD452Ter1192CD311 0.03-0.4 32, 41, 99
Fibroblastic reticular
stromal cells
CD1461 0.02-0.08 100-102 CD452Ter1192CXCL12GFP1 0.02-0.04 31, 33
CD2711 0.03 CD452Ter1192CD1401LepR1 0.3
CD1461CD511CD140a1 0.1
Estimated ranges of frequencies of different hematopoietic and nonhematopoietic populations in human and mouse BM expressed as percentages of BM mononuclear cells (BMMNCs).
*Estimation based on microscopic examination of BM, not flow cytometry.
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described in the BM. Rather than stable, well-demarcated zones,
studies on BM organization have revealed the presence of
microdomains defined by interactions of 2 or more cell types,
which associate into functional units in which exchange of key
signals leads to maintenance or differentiation of specific de-
velopmental stages. Cellular “niches” in BM have been reported for
HSPCs, common lymphoid progenitors (CLPs), B-cell progenitors,
erythrocytes, regulatory T cells, CD4/CD8 memory and plasma
A
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Figure 2. Structural organization of BM tissues. (A) BM stromal microarchitecture. The microarchitecture of the vascular system has been studied in detail in the mouse femoral
cavity. A central artery (ca) penetrates the cavity through the nutrient canal and splits into ascending and descending branches, which run longitudinally, arborizing into smaller radial
arteries that migrate toward endosteal regions. In the proximity of endosteum, arteries give rise to a dense plexus of arterioles that travel along the cortical bone area and eventually
develop into venous vessels, of fenestrated endothelium, termed sinusoidal. Sinusoids form a labyrinth that extends inward and merges in a big central collecting sinus (cs) that
drains into peripheral circulation (see also Figure 1). Thin periosteal arteries also penetrate the bone and merge with arteriolar vessels in endosteal regions, connecting BM and bone
circulation. In trabecular bone areas, multiple smaller arteries enter the marrow cavities and give rise to sinusoidal networks along the endosteal surface of trabeculae. CXCL12-
abundant fibroblastic reticular cells (CARc) extend throughout the entire cavity in the form of dense networks. Nestin-GFPhi NG21 (nes) elongated cells run adjacent to arteries and
arterioles and bundles of nonmyelinating Schwann cells (nmsc), which ensheath adrenergic nerves. Mature osteoblasts (ob) line endosteal surfaces and are mostly derived from
reticular progenitors of osetoadipogenic potential. The emergence of adipocytes (adip) takes place gradually during aging and can be abrupt and prominent in certain pathological
conditions. (B) Schematic representation of cell or developmental stage-specific niches. (i) HSC niches: a number of studies have determined that HSCs are found scattered
throughout BM tissues adjoining the extraluminal surface of sinusoidal endothelial cells and in contact with stem cell factor–producing, LepR1 CAR cells13,14,50,90 and, in some
cases, to megakaryocytes.103,104 In addition, a minor fraction enriched in quiescent HSCs has been reported to localize in a protective niche adjacent to nonpermeable arterioles,
under the regulatory influence of neighboring Nestin-GFPhi, NG21 mesenchymal cells (nes) and nonmyelinating Schwann cells (in yellow).32,55,65 (ii) B-cell progenitors have been
suggested to sequentially migrate along different niches as they progress through maturation. Early stage pre-pro B cells are mostly found adjacent to the cell bodies of CAR cells
and migrate toward IL-7–expressing CAR cells as they enter the pro B cell stage. Mature B2201IgM1 B cells, in turn, move away from both stromal cell types.105 The latest stages of
B-cell maturation occur intravascularly, within sinusoids, where the dynamic behavior of immature B cells has been visualized in vivo.106 In addition, early pro B cells (B2201CD431)
have been shown to accumulate in endosteal zones and gradually decrease in frequency toward bone-distal marrow regions.68 (iii) Megakaryocytes (Mk) are found in close
adjacency to the endothelial surface of sinusoidal vessel wall, which they traverse in the form of protrusions from which proplatelets are continuously shedded into the venous
circulatory system.107 Red blood cell development takes place in so-called erythoblastic islands (Ei), where erythroid precursors proliferate, enucleate, and terminally differentiate
into reticulocytes around a central macrophage.108 Plasma B cells are long-lived antibody-secreting cells that have been found in physical association to CAR cells, megakaryoctes,
and eosinophils (eos).109-111 (iv) Although a significant fraction (30%) of early lymphoid progenitors (Lin2IL7-ra1) has been shown to lie proximal to mature, bone-lining
osteoblasts,48 the vast majority of phenotypically defined CLPs are in contact with IL-7–expressing CAR cells.50 Quiescent CD41memory T cells are found scattered throughout the
BM in contact with perisinusoidal IL-7–secreting stromal cells.112 Regulatory T cells (Tregs) have been reported to lodge in close proximity to the endosteum of trabecular bone.
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B cells, among others (summarized in Figure 2 and described in
detail by Mercier et al63). Many of the niches are constructed
around diverse microvessel types, which distinctly regulate access
to nutrients, oxygen, and metabolites derived from circulating
blood.64-66
Nevertheless, for the most part, available data on BM subcompart-
ments remain fragmentary, and a broader picture integrating
comprehensive spatial patterns and number of niches in an
organ-wide context is lacking. In fact, only a limited number of
studies have analyzed cell subset localization at a global scale and
thus explored the hypothesis that hematopoietic cells distribute in a
nonarbitrary fashion in accordance to a defined zonation of the BM
landscape. In early work, Lord et al employed functional assays
to define the frequency of primitive progenitor cells in regions of
tissue that were microdissected along the longitudinal axis of the
diaphysis of femoral cavities. These studies revealed that progenitor
cells endowed with hematopoietic colony-forming capacity were
enriched in the proximity of endosteal zones.67 Using quantitative
imaging of entire BM sections, we confirmed a tendency of
phenotypically defined progenitors to spatially distribute along
gradients, accumulating in bone-proximal regions and gradually
decreasing in frequency toward central areas.13 Moreover, early
lymphoid progenitor IL-7 receptor–expressing cells have been
observed to preferentially distribute toward the proximity of
endosteal surfaces and functionally depend on osteoblast-derived
signals.48,68 Collectively, these data point to the possibility that
progression downstream of the hematopoietic hierarchy could
correlate with a centripetal movement away from bone surfaces
toward deeper regions of the BM. However, this conceptually
attractive hypothesis is challenged by 2 recent studies. First, a 2D
spatial analysis of the tissue distribution adopted by CLPs suggests
these progenitors rather localize in bone-distal regions, in close
interaction with IL-7–expressing CAR cells50. Second, the first
global mapping of thousands of genetically labeled HSPCs within
intact 3D marrow plugs using deep tissue imaging clearly un-
covered their significant accumulation in central BM zones.14 Thus,
whether some sort of spatial correlate of the hierarchical organi-
zation of the hematopoietic compartment can be found in its
microanatomical organization in the BM remains to be defined.
Outlook and future challenges
The notion that structure and function are inextricably linked is a
fundamental tenet, which applies to all scales of biological systems.
Although the hematopoietic hierarchy has been hailed as the best
characterized somatic stem cell–based system, an integrated model
of how the system functions in the defined structural context of BM
microanatomy is largely lacking. Just as the quest for the identification
of HSCs has historically been the driving force for the dissection of
the hematopoietic system, much of what has been learned on BM
microarchitecture has been gleaned from formative studies in search
of the HSC niche.69 Indeed, significant progress has been achieved.
However, beyond the precise nature of HSC niches, much is still
to be learned on the spatiotemporal dynamics of hematopoiesis.
A comprehensive systems-based approach will be necessary to
understand how the plethora of individual components assemble
to form the integrated cellular wiring required for hematopoietically
competent BM tissues. Key unresolved questions relate to the global
distribution of oligocellular niches described so far, how they are built
and dismantled, and the hierarchical and functional relationships
established by their components. For their ability to generate global,
high-resolution, and multidimensional data, quantitative 3D imaging
techniques will be vital when addressing these questions and
determining how disturbances of canonical 3D organization patterns
relate to disease states in BM. This will also be of key importance in
light of studies that demonstrate that functional and structural
remodeling of the 3D tissue microenvironment are essential and
necessary for malignant transformation and tumor progression in
certain cancers, including those of the hematopoietic system.70-72
The knowledge gained will have further implications for antineoplastic
therapies and regenerative medicine. The full recapitulation of the
conditions of differentiation and maintenance of HSCs in vitro, and
the design of ideal strategies for hematopoietic tissue engineering,
will inevitably require the complementation of comprehensive mole-
cular and cellular data with essential information on native tissue
microarchitecture.
Acknowledgments
CXCL12-GFP mice were kindly provided by Takashi Nagasawa
(Osaka University). The authors thank Stephan Isringhausen for the
images depicted in Figure 1.
This work was supported by the Swiss National Science
Foundation (31003A_159597/1), the Vontobel Foundation (Zurich,
Switzerland) and the Helmut Horten Foundation (Lugano,
Switzerland) (C.N.-A.); and the Swiss National Science Foundation
(310030_146528/1) and the Clinical Research Priority Program
“Human Hemato-Lymphatic Diseases” of the University of Zurich
(M.G.M.).
Authorship
Contribution: C.N.-A. and M.G.M. wrote the manuscript and pre-
pared the figures.
Conflict-of-interest disclosure: The authors declare no compet-
ing financial interests.
ORCID profiles: C.N.-A., 0000-0003-0415-259X.
Correspondence: Cesar Nombela-Arrieta, Hematology, Uni-
versity Hospital and University of Zurich, Ha¨ldeliweg 4, CH-8044
Zurich, Switzerland; e-mail: cesar.nombelaarrieta@usz.ch.
References
1. Peabody FW. A study of hyperplasia of the bone marrow in man. Am J Pathol. 1926;2(6):487-502.
2. Cooper B. The origins of bone marrow as the seedbed of our blood: from antiquity to the time of Osler. Proc Bayl Univ Med Cent. 2011;24(2):115-118.
3. Kaushansky K, Lichtman M, Beutler E, et al. Williams Hematology, 8th ed. New York: McGraw-Hill Professional; 2010.
4. Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood. 2015;125(17):2605-2613.
412 NOMBELA-ARRIETA and MANZ 14 FEBRUARY 2017 x VOLUME 1, NUMBER 6
5. Domen J, Wagers A, Weissman IL. Bone marrow (Hematopoietic) stem cells. In: Regenerative Medicine. Washington, DC: Department of Health and
Human Services; 2006:13-34.
6. Weiss L. The haemopoietic microenvironment of bone marrow: an ultrastructural study of the interactions of blood cells, stroma and blood vessels. Ciba
Found Symp. 1980;71:3-19.
7. Joseph C, Quach JM, Walkley CR, Lane SW, Lo Celso C, Purton LE. Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic
models, lineage tracing, and imaging strategies. Cell Stem Cell. 2013;13(5):520-533.
8. Sumen C, Mempel TR, Mazo IB, von Andrian UH. Intravital microscopy: visualizing immunity in context. Immunity. 2004;21(3):315-329.
9. Richardson DS, Lichtman JW. Clarifying tissue clearing. Cell. 2015;162(2):246-257.
10. Susaki EA, Ueda HR.Whole-body and whole-organ clearing and imaging techniques with single-cell resolution: toward organism-level systems biology in
mammals. Cell Chem Biol. 2016;23(1):137-157.
11. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods. 2010;7(8):603-614.
12. Eliceiri KW, Berthold MR, Goldberg IG, et al. Biological imaging software tools [published correction appears in Nat Methods. 2012;9(10):1031]. Nat
Methods. 2012;9(7):697-710.
13. Nombela-Arrieta C, Pivarnik G, Winkel B, et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the
bone marrow microenvironment. Nat Cell Biol. 2013;15(5):533-543.
14. Acar M, Kocherlakota KS, Murphy MM, et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature. 2015;
526(7571):126-130.
15. Inra CN, Zhou BO, Acar M, et al. A perisinusoidal niche for extramedullary haematopoiesis in the spleen. Nature. 2015;527(7579):466-471.
16. Ellis RE. The distribution of active bone marrow in the adult. Phys Med Biol. 1961;5(3):255-258.
17. Woodard HQ, Holodny E. A summary of the data of Mechanik on the distribution of human bone marrow. Phys Med Biol. 1960;5(1):57-59.
18. Snyder WS, Cook MJ, Nasset ES, Karhausen LR. Report of the Task Group on Reference Man. International Commission on Radiological Protection
No. 23. Oxford: Pergamon Press; 1975.
19. Rosahn PD. The weight of the normal heart in adult males. Yale J Biol Med. 1941;14(2):209-223.
20. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354(19):2034-2045.
21. Palis J. Primitive and definitive erythropoiesis in mammals. Front Physiol. 2014;5:3.
22. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest. 1969;48(6):963-974.
23. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest. 1976;58(3):705-715.
24. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990;110(4):
1001-1020.
25. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533.
26. Kiel MJ, Iwashita T, Yilmaz O¨H, Morrison SJ. Spatial differences in hematopoiesis but not in stem cells indicate a lack of regional patterning in definitive
hematopoietic stem cells. Dev Biol. 2005;283(1):29-39.
27. Kondo M, Wagers AJ, Manz MG. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21:
759-806.
28. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl
Acad Sci USA. 2011;108(50):20012-20017.
29. Geiger H, de Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat Rev Immunol. 2013;13(5):376-389.
30. Niswander LM, McGrath KE, Kennedy JC, Palis J. Improved quantitative analysis of primary bone marrowmegakaryocytes utilizing imaging flow cytometry.
Cytometry A. 2014;85(4):302-312.
31. Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed
by adult bone marrow. Cell Stem Cell. 2014;15(2):154-168.
32. Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502(7473):637-643.
33. Casanova-Acebes M, Pitaval C, Weiss LA, et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell. 2013;153(5):
1025-1035.
34. Kusumbe AP, Ramasamy SK, Itkin T, et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature. 2016;532(7599):
380-384.
35. Smith-Berdan S, Schepers K, Ly A, Passegue´ E, Forsberg EC. Dynamic expression of the Robo ligand Slit2 in bone marrow cell populations.Cell Cycle.
2012;11(4):675–682.
36. Junt T, Scandella E, Ludewig B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol. 2008;
8(10):764-775.
37. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008;3(suppl 3):S131-S139.
38. Lassailly F, Foster K, Lopez-Onieva L, Currie E, Bonnet D. Multimodal imaging reveals structural and functional heterogeneity in different bone marrow
compartments: functional implications on hematopoietic stem cells. Blood. 2013;122(10):1730-1740.
14 FEBRUARY 2017 x VOLUME 1, NUMBER 6 MICROANATOMY OF THE BONE MARROW 413
39. Scadden DT. Rethinking stroma: lessons from the blood. Cell Stem Cell. 2012;10(6):648-649.
40. Rafii S, Butler JM, Ding B-S. Angiocrine functions of organ-specific endothelial cells. Nature. 2016;529(7586):316-325.
41. Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014;507(7492):
323-328.
42. Li XM, Hu Z, Jorgenson ML, Slayton WB. High levels of acetylated low-density lipoprotein uptake and low tyrosine kinase with immunoglobulin and
epidermal growth factor homology domains-2 (Tie2) promoter activity distinguish sinusoids from other vessel types in murine bone marrow. Circulation.
2009;120(19):1910-1918.
43. Lim S, Zhang Y, Zhang D, et al. VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization. Cell
Reports. 2014;9(2):569-580.
44. Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal
endothelial cells. Cell Stem Cell. 2009;4(3):263-274.
45. Worthley DL, Churchill M, Compton JT, et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell. 2015;
160(1-2):269-284.
46. Chan CKF, Seo EY, Chen JY, et al. Identification and specification of the mouse skeletal stem cell. Cell. 2015;160(1-2):285-298.
47. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481(7382):
457-462.
48. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature. 2013;495(7440):231-235.
49. Greenbaum A, Hsu Y-MS, Day RB, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance.Nature. 2013;
495(7440):227-230.
50. Cordeiro Gomes A, Hara T, Lim VY, et al. Hematopoietic stem cell niches produce lineage-instructive signals to control multipotent progenitor
differentiation. Immunity. 2016;45(6):1219-1231.
51. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow
stromal cell niches. Immunity. 2006;25(6):977-988.
52. Omatsu Y, Sugiyama T, Kohara H, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche.
Immunity. 2010;33(3):387-399.
53. Park D, Spencer JA, Koh BI, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.Cell
Stem Cell. 2012;10(3):259-272.
54. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.Cell.
2007;131(2):324-336.
55. Yamazaki S, Ema H, Karlsson G, et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche.Cell. 2011;
147(5):1146-1158.
56. Hu X, Garcia M, Weng L, et al. Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. Nat Commun. 2016;7:
13095.
57. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol. 2008;20(4):429-434.
58. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic
microenvironment. Nature. 2009;460(7252):259-263.
59. Scheller EL, Doucette CR, Learman BS, et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow
adipose tissues. Nat Commun. 2015;6:7808.
60. Scheller EL, Cawthorn WP, Burr AA, Horowitz MC, MacDougald OA. Marrow adipose tissue: trimming the fat. Trends Endocrinol Metab. 2016;27(6):
392-403.
61. Malara A, Currao M, Gruppi C, et al. Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and
laminin. Stem Cells. 2014;32(4):926-937.
62. Nakamura-Ishizu A, Okuno Y, Omatsu Y, et al. Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for
hematopoietic regeneration. Blood. 2012;119(23):5429-5437.
63. Mercier FE, Ragu C, Scadden DT. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol. 2011;12(1):49-60.
64. Spencer JA, Ferraro F, Roussakis E, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals.Nature. 2014;508(7495):
269-273.
65. Itkin T, Gur-Cohen S, Spencer JA, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532(7599):323-328.
66. Nombela-Arrieta C, Silberstein LE. The science behind the hypoxic niche of hematopoietic stem and progenitors. Hematology Am Soc Hematol Educ
Program. 2014;2014(1):542-547.
67. Lord BI, Testa NG, Hendry JH. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood. 1975;46(1):65-72.
68. Park S-Y, Wolfram P, Canty K, et al. Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments.
J Immunol. 2013;190(3):1094-1102.
69. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327-334.
414 NOMBELA-ARRIETA and MANZ 14 FEBRUARY 2017 x VOLUME 1, NUMBER 6
70. Bissell MJ, Hines WC. Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;
17(3):320-329.
71. Raaijmakers MHGP, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;
464(7290):852-857.
72. Kode A, Manavalan JS, Mosialou I, et al. Leukaemogenesis induced by an activating b-catenin mutation in osteoblasts. Nature. 2014;506(7487):
240-244.
73. Pegg DE. A quantitative study of bone marrow grafting: implications for human bone marrow infusion. Br J Cancer. 1962;16(3):400-416.
74. Vogel AW. Comparison of simultaneously incurred damage to bone marrow and tumor tissue of animals treated with anticancer agents. Cancer Res.
1961;21:636-641.
75. Durbin PW, Jeung N, Kullgren B, Clemons GK. Gross composition and plasma and extracellular water volumes of tissues of a reference mouse. Health
Phys. 1992;63(4):427-442.
76. Sambuceti G, Brignone M, Marini C, et al. Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT
imaging. Eur J Nucl Med Mol Imaging. 2012;39(8):1326-1338.
77. Riches AC, Sharp JG, Thomas DB, Smith SV. Blood volume determination in the mouse. J Physiol. 1973;228(2):279-284.
78. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol
Ind Health. 1997;13(4):407-484.
79. Harrison WJ. The total cellularity of the bone marrow in man. J Clin Pathol. 1962;15(3):254-259.
80. Boggs DR. The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol. 1984;16(3):277-286.
81. Colvin GA, Lambert J-F, Abedi M, et al. Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in
stem cell biology. Leukemia. 2004;18(3):575-583.
82. Rosinski M, Yarmush ML, Berthiaume F. Quantitative dynamics of in vivo bone marrow neutrophil production and egress in response to injury and
infection. Ann Biomed Eng. 2004;32(8):1109-1120.
83. Geerman S, Hickson S, Brasser G, Pascutti MF, Nolte MA. Quantitative and qualitative analysis of bone marrow CD8(1) T cells from different bones
uncovers a major contribution of the bone marrow in the vertebrae. Front Immunol. 2016;6(4):660.
84. Hardouin P, Rharass T, Lucas S. Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol (Lausanne). 2016;7(4):85.
85. Blebea JS, Houseni M, Torigian DA, et al. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl
Med. 2007;37(3):185-194.
86. Doucette CR, Horowitz MC, Berry R, et al. A high fat diet increases bone marrow adipose tissue (MAT) but does not alter trabecular or cortical bone mass
in C57BL/6J mice. J Cell Physiol. 2015;230(9):2032-2037.
87. Abkowitz JL, Catlin SN, McCallie MT, Guttorp P. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals.Blood. 2002;
100(7):2665-2667.
88. Martin RA, Brott DA, Zandee JC, McKeel MJ. Differential analysis of animal bone marrow by flow cytometry. Cytometry. 1992;13(6):638-643.
89. Yang M, Bu¨sche G, Ganser A, Li Z. Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy
subjects. Ann Hematol. 2013;92(5):587-594.
90. Kiel MJ, Yilmaz O¨H, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and
reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121.
91. Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic commonmyeloid progenitors. Proc Natl Acad Sci USA. 2002;
99(18):11872-11877.
92. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):
193-197.
93. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91(5):661-672.
94. Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, et al. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Haematologica. 2015;100(3):315-323.
95. Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005;201(11):
1771-1780.
96. Ciudad J, Orfao A, Vidriales B, et al. Immunophenotypic analysis of CD191 precursors in normal human adult bone marrow: implications for minimal
residual disease detection. Haematologica. 1998;83(12):1069-1075.
97. Brooimans RA, Kraan J, van Putten W, Cornelissen JJ, Lo¨wenberg B, Gratama JW. Flow cytometric differential of leukocyte populations in normal bone
marrow: influence of peripheral blood contamination. Cytometry B Clin Cytom. 2009;76B(1):18-26.
98. Hettinger J, Richards DM, Hansson J, et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol. 2013;14(8):821-830.
99. Smith-Berdan S, Nguyen A, Hong MA, Forsberg EC. ROBO4-mediated vascular integrity regulates the directionality of hematopoietic stem cell
trafficking. Stem Cell Rep. 2015;4(2):255-268.
100. Tormin A, Li O, Brune JC, et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood.
2011;117(19):5067-5077.
14 FEBRUARY 2017 x VOLUME 1, NUMBER 6 MICROANATOMY OF THE BONE MARROW 415
101. Pinho S, Lacombe J, Hanoun M, et al. PDGFRa and CD51 mark human nestin1 sphere-forming mesenchymal stem cells capable of hematopoietic
progenitor cell expansion. J Exp Med. 2013;210(7):1351-1367.
102. Isern J, Martı´n-Antonio B, Ghazanfari R, et al. Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell
Reports. 2013;3(5):1714-1724.
103. Bruns I, Lucas D, Pinho S, et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014;20(11):
1315-1320.
104. Zhao M, Perry JM, Marshall H, et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells.
Nat Med. 2014;20(11):1321-1326.
105. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol. 2006;6(2):107-116.
106. Pereira JP, An J, Xu Y, Huang Y, Cyster JG. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol.
2009;10(4):403-411.
107. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007;317(5845):1767-1770.
108. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3):470-478.
109. Tokoyoda K, Zehentmeier S, Chang H-D, Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol. 2009;
39(8):2095-2099.
110. Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116(11):
1867-1875.
111. Chu VT, Fro¨hlich A, Steinhauser G, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12(2):
151-159.
112. Tokoyoda K, Hauser AE, Nakayama T, Radbruch A. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol. 2010;10(3):
193-200.
113. Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature. 2011;
474(7350):216-219.
416 NOMBELA-ARRIETA and MANZ 14 FEBRUARY 2017 x VOLUME 1, NUMBER 6
